Breakthrough Alzheimer's Drug
The FDA has approved Biogen's new Alzheimer's drug, marking the first new treatment in almost two decades. While it doesn't cure the disease, it mitigates its progression. Despite controversy and resignations from the FDA advisory panel, the drug offers hope for sufferers at a cost of $55,000. In this episode, the hosts delve into the science behind the drug and discuss its implications for journalism and social media.In this clip
From this podcast
All-In Podcast
E35: Biogen's controversial Alzheimer's drug approval, the billionaire space race, Bitcoin & more
Related Questions